skip to content

Market News

Peel Hunt cuts earnings by 30% for Hikma

21 August 2017 10:27

Peel Hunt has cut its earnings by 30% for Hikma Pharma (LON:HIK), while the price target falls to £13.90 from £21.50.

The downgrades were made in the wake of last week's profit warning. The interim results revealed the firm had been hit by a further downturn in the fortunes of its generics business.

Peel's recommendation remains 'hold'.

"The shares have been swift to discount these incremental concerns (the stock is down around 15% since the first-half release); so upside to our target price remains despite our downgrades, keeping us at hold," the broker said in a note to clients.

At 10:27am: (LON:HIK) Hikma Pharmaceuticals PLC share price was +15p at 1134p

Story provided by StockMarketWire.com

Related Company: HIK

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

aew-banner-180x255.jpg -

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.